Cherkashova Elvira A, Namestnikova Daria D, Gubskiy Ilya L, Revkova Veronica A, Sukhinich Kirill K, Melnikov Pavel A, Abakumov Maxim A, Savina Galina D, Chekhonin Vladimir P, Gubsky Leonid V, Yarygin Konstantin N
Department of Neurology, Neurosurgery and Medical Genetics, Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, 117977 Moscow, Russia.
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, 117513 Moscow, Russia.
Life (Basel). 2023 Jan 20;13(2):288. doi: 10.3390/life13020288.
Systemic transplantation of mesenchymal stem cells (MSCs) is a promising approach for the treatment of ischemia-associated disorders, including stroke. However, exact mechanisms underlying its beneficial effects are still debated. In this respect, studies of the transplanted cells distribution and homing are indispensable. We proposed an MRI protocol which allowed us to estimate the dynamic distribution of single superparamagnetic iron oxide labeled MSCs in live ischemic rat brain during intravenous transplantation after the transient middle cerebral artery occlusion. Additionally, we evaluated therapeutic efficacy of cell therapy in this rat stroke model. According to the dynamic MRI data, limited numbers of MSCs accumulated diffusely in the brain vessels starting at the 7th minute from the onset of infusion, reached its maximum by 29 min, and gradually eliminated from cerebral circulation during 24 h. Despite low numbers of cells entering brain blood flow and their short-term engraftment, MSCs transplantation induced long lasting improvement of the neurological deficit, but without acceleration of the stroke volume reduction compared to the control animals during 14 post-transplantation days. Taken together, these findings indicate that MSCs convey their positive action by triggering certain paracrine mechanisms or cell-cell interactions or invoking direct long-lasting effects on brain vessels.
间充质干细胞(MSCs)的全身移植是治疗包括中风在内的缺血相关疾病的一种有前景的方法。然而,其有益效果的具体机制仍存在争议。在这方面,对移植细胞分布和归巢的研究是不可或缺的。我们提出了一种磁共振成像(MRI)方案,该方案使我们能够在短暂大脑中动脉闭塞后静脉移植期间,估计超顺磁性氧化铁标记的单个MSCs在活体缺血大鼠脑中的动态分布。此外,我们评估了该大鼠中风模型中细胞治疗的疗效。根据动态MRI数据,从输注开始第7分钟起,有限数量的MSCs开始在脑血管中弥漫性聚集,在29分钟时达到最大值,并在24小时内逐渐从脑循环中清除。尽管进入脑血流的细胞数量较少且短期植入,但在移植后14天内,与对照动物相比,MSCs移植诱导了神经功能缺损的长期改善,但并未加速脑梗死体积的缩小。综上所述,这些发现表明,MSCs通过触发某些旁分泌机制或细胞间相互作用或对脑血管产生直接的长期影响来发挥其积极作用。